#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA2400677	Binding	Activation of human recombinant AMPK at 20 uM after 30 mins relative to control	Homo sapiens	2	ALA2396611	single protein format	Scientific Literature
2.	ALA2401228	Binding	Activation of AMPK in rat L6 cells assessed as increase of [3H]dGlc uptake after 5 hrs	Rattus norvegicus	6	ALA2396611	cell-based format	Scientific Literature
3.	ALA2401232	Binding	Activation of AMPK in rat L6 cells assessed as increase of [3H]dGlc uptake at 10 to 200 uM	Rattus norvegicus	3	ALA2396611	cell-based format	Scientific Literature
4.	ALA2401233	Binding	Activation of AMPK in rat L6 cells assessed as increase of [3H]dGlc uptake at 5 uM after 5 hrs relative to control	Rattus norvegicus	1	ALA2396611	cell-based format	Scientific Literature
5.	ALA4495582	Functional	SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate	Severe acute respiratory syndrome coronavirus 2	7,212	ALA4495564	assay format	SARS-CoV-2 Screening Data 2020-21
6.	ALA4513082	Functional	Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging	Chlorocebus sabaeus	7,212	ALA4495565	organism-based format	SARS-CoV-2 Screening Data 2020-21
7.	ALA5303713	Functional	Inhibition of SARS-CoV-2 3CL-Pro proteolytic cleavage of a dual-labeled substrate by FRET.	Severe acute respiratory syndrome coronavirus 2	64	ALA5303709	assay format	EU-OPENSCREEN dataset
8.	ALA5303714	Functional	Inhibition of SARS-CoV-2 3CL-Pro proteolytic cleavage of a dual-labeled substrate by FRET at 1mM DTT.	Severe acute respiratory syndrome coronavirus 2	64	ALA5303710	assay format	EU-OPENSCREEN dataset